Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

VitaNova Life Sciences (YJGJ) Net Income (2017 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed Net Income for 9 consecutive years, with $35810.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Income rose 9.69% year-over-year to $35810.0, compared with a TTM value of $862819.0 through Oct 2025, up 470.26%, and an annual FY2025 reading of $850746.0, up 503.94% over the prior year.
  • Net Income was $35810.0 for Q4 2025 at VitaNova Life Sciences, up from -$46301.0 in the prior quarter.
  • Across five years, Net Income topped out at $800332.0 in Q2 2025 and bottomed at -$55211.0 in Q3 2024.
  • Average Net Income over 5 years is $53405.6, with a median of $2367.5 recorded in 2022.
  • The sharpest move saw Net Income plummeted 1236.22% in 2023, then soared 3929.4% in 2024.
  • Year by year, Net Income stood at $15009.0 in 2021, then crashed by 82.67% to $2601.0 in 2022, then tumbled by 436.6% to -$8755.0 in 2023, then surged by 472.9% to $32647.0 in 2024, then rose by 9.69% to $35810.0 in 2025.
  • Business Quant data shows Net Income for YJGJ at $35810.0 in Q4 2025, -$46301.0 in Q3 2025, and $800332.0 in Q2 2025.